Berzofsky, J.A.: Epitope selection and design of synthetic vaccines. Molecular approaches to enhancing immunogenicity and cross-reactivity of engineered vaccines. Ann. N.Y. Acad. Sci. 1993, 690:256–264.
Davenport, M.P., and Hill, A.V.: Reverse immunogenetics: from HLA-disease associations to vaccine candidates. Mol. Med. Today 1996, 2:38–45.
Hill, A.V.: Pre-erythrocytic malaria vaccines: towards greater efficacy. Nat. Rev. Immunol. 2006, 6:21–32.
Hoffman, S.L., Rogers, W.O., Carucci, D.J., and Venter, J.C.: From genomics to vaccines: malaria as a model system. Nat. Med. 1998, 4:1351–1353.
Ottenhoff, T.H., Doherty, T.M., Dissel, J.T., Bang, P., Lingnau, K., Kromann, I., and Andersen, P.: First in humans: a new molecularly defined vaccine shows excellent safety and strong induction of long-lived Mycobacterium tuberculosis-specific Th1-cell like responses. Hum. Vaccin. 2010, 6:1007–1015.
Zwaveling, S., Ferreira Mota, S.C., Nouta, J., Johnson, M., Lipford, G.B., Offringa, R., van der Burg, S.H., and Melief, C.J.: Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides. J. Immunol. 2002, 169:350–358.
16-29 Adjuvants are important for enhancing the immunogenicity of vaccines, but few are approved for use in humans.
Coffman, R.L., Sher, A., and Seder, R.A.: Vaccine adjuvants: putting innate immunity to work. Immunity 2010, 33:492–503.
Hartmann, G., Weiner, G.J., and Krieg, A.M.: CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc. Natl Acad. Sci. USA 1999, 96:9305–9310.
Palucka, K., Banchereau, J., and Mellman, I.: Designing vaccines based on biology of human dendritic cell subsets. Immunity 2010, 33:464–478.
Persing, D.H., Coler, R.N., Lacy, M.J., Johnson, D.A., Baldridge, J.R., Hershberg, R.M., and Reed, S.G.: Taking toll: lipid A mimetics as adjuvants and immunomodulators. Trends Microbiol. 2002, 10:S32–S37.
Pulendran, B.: Modulating vaccine responses with dendritic cells and Toll-like receptors. Immunol. Rev. 2004, 199:227–250.
Takeda, K., Kaisho, T., and Akira, S.: Toll-like receptors. Annu. Rev. Immunol. 2003, 21:335–376.
16-30 Protective immunity can be induced by DNA-based vaccination.
Donnelly, J.J., Ulmer, J.B., Shiver, J.W., and Liu, M.A.: DNA vaccines. Annu. Rev. Immunol. 1997, 15:617–648.